BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 18097622)

  • 1. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
    Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
    Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
    Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
    J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.
    Nishikawa Y; Wang M; Carr BI
    J Cell Physiol; 1998 Sep; 176(3):612-23. PubMed ID: 9699514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
    Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
    J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
    Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
    Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of matrix metalloproteinases-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability.
    Jiang X; Zeng HS; Guo Y; Zhou ZB; Tang BS; Li FK
    Chin Med J (Engl); 2004 Dec; 117(12):1825-9. PubMed ID: 15603712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.
    Yamada SD; Baldwin RL; Karlan BY
    Gynecol Oncol; 1999 Oct; 75(1):72-7. PubMed ID: 10502429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte 'priming' and increase in transforming growth factor-beta1 mRNA expression are delayed in hypothyroid versus euthyroid rats during liver regeneration.
    Moro L; Perlino E; Marra E; Greco M
    Int J Mol Med; 2006 Jun; 17(6):1063-8. PubMed ID: 16685417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK506, transforming growth factor-beta1 and mesangial matrix synthesis: parallels and differences compared with cyclosporine A.
    Waiser J; Dell K; Kreutzkamp J; Böhler T; Budde K; Peters H; Neumayer HH
    Cytokine; 2006 Jan; 33(2):59-65. PubMed ID: 16458528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas.
    Woszczyk D; Gola J; Jurzak M; Mazurek U; Mykała-Cieśla J; Wilczok T
    Med Sci Monit; 2004 Jan; 10(1):CR33-7. PubMed ID: 14704634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta receptor types I and II are differentially expressed during corneal epithelial wound repair.
    Zieske JD; Hutcheon AE; Guo X; Chung EH; Joyce NC
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1465-71. PubMed ID: 11381048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TGF-beta type III receptor is localized to the medial edge epithelium during palatal fusion.
    Cui XM; Shuler CF
    Int J Dev Biol; 2000 Jun; 44(4):397-402. PubMed ID: 10949049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transforming growth factor beta isoforms and their receptors in malignant fibrous histiocytoma of soft tissues.
    Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Nakatani T; Kurosaka M
    Clin Cancer Res; 2004 Sep; 10(17):5804-7. PubMed ID: 15355909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis.
    Stadnicki A; Machnik G; Klimacka-Nawrot E; Wolanska-Karut A; Labuzek K
    Int Immunopharmacol; 2009 Jun; 9(6):761-6. PubMed ID: 19285572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
    Budasz-Rwiderska M; Jank M; Motyl T
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
    Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.